For research use only. Not for therapeutic Use.
Monomethyl auristatin E intermediate-11 is an intermediate reactant in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs)[1].
Catalog Number | I040445 |
CAS Number | 870640-62-3 |
Synonyms | (2S,3S)-2-[benzyl(methyl)amino]-3-methylpentan-1-ol |
Molecular Formula | C14H23NO |
Purity | ≥95% |
InChI | InChI=1S/C14H23NO/c1-4-12(2)14(11-16)15(3)10-13-8-6-5-7-9-13/h5-9,12,14,16H,4,10-11H2,1-3H3/t12-,14+/m0/s1 |
InChIKey | JPXSDNBZAYWWCL-GXTWGEPZSA-N |
SMILES | CCC(C)C(CO)N(C)CC1=CC=CC=C1 |
Reference | [1]. Lisa Buckel, et al. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-87. |